Choose another country or region to see content specific to your location and shop online.
En raison des retards de livraison et de la réduction des effectifs chez les transporteurs, les commandes passées après le 16 décembre pourraient arriver le 10 janvier ou après ; les délais de livraison ne sont pas garantis.
Septodont Septanest N Silver Articaine HCI 4% with 1:200,000 epinephrine injection 50/box
SKU:
VMSEPT-99146
Mfr. P/N:
N/A
Your Price
153,68 $
Your Price
153,68 $/
153,68 $/
reg.
Connexionfor discount
-%
Disponibilité:En stock
Check Warehouse Availability
Warehouse
Disponible
Incoming
Date
Edmonton AB
1
0
-
TOTAL
1
Details
Q&A
Avis
Retours
Details
Due to Health Canada policy this item is non returnable.
Indications
Local or loco-regional dental anesthesia in patients of at least 4 years old
Features & benefits
Fast onset to avoid delay before effective analgesia is achieved
No-methylparaben formulation to avoid allergic reactions on sensitive patients
Latex-free plungers and seals
Terminal sterilization of product/cartridges for safe use
Presentation
Item #99146: Box containing 50 cartridges x 1.7 ml
Risk information
Septanest
N is indicated for local, infiltrative, or conductive anesthesia in
both simple and complex dental procedures. Septanest N with epinephrine
1:100,000 is preferred during operative or surgical procedures when
improved visualization of the surgical field is desirable. Reactions to
Septanest N (pain and headache, for example, or convulsions or
respiratory arrest following accidental intravascular injection) are
characteristic of those associated with other amide-type local
anesthetics. Septanest N contains sodium metabisulfite, a sulfite that
may cause allergic-type reactions including anaphylactic symptoms and
life-threatening or less severe asthmatic episodes in certain
susceptible people. Accidental intravascular injection may be associated
with convulsions, followed by central nervous system or
cardiorespiratory depression and coma, progressing ultimately to
respiratory arrest. Dental practitioners and/or clinicians who employ
local anesthetic agents should be well versed in diagnosis and
management of emergencies that may arise from their use. Resuscitative
equipment, oxygen, and other resuscitative drugs should be available for
immediate use. Septanest N, along with other local anesthetics, is
capable of producing methemoglobinemia. The clinical signs of
methemoglobinemia are cyanosis of the nail beds and lips, fatigue and
weakness. If methemoglobinemia does not respond to administration of
oxygen, administration of methylene blue intravenously 1-2 mg/kg body
weight over a 5 minute period is recommended. Please see the Package
Insert for prescribing information.
